CALO', Valentina
 Distribuzione geografica
Continente #
NA - Nord America 6.630
EU - Europa 3.908
AS - Asia 2.878
SA - Sud America 429
AF - Africa 58
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.910
Nazione #
US - Stati Uniti d'America 6.535
SG - Singapore 1.021
RU - Federazione Russa 892
CN - Cina 818
IT - Italia 637
DE - Germania 619
FI - Finlandia 604
BR - Brasile 351
HK - Hong Kong 284
VN - Vietnam 248
UA - Ucraina 238
GB - Regno Unito 197
PL - Polonia 149
FR - Francia 129
IE - Irlanda 125
JP - Giappone 109
SE - Svezia 101
IN - India 79
KR - Corea 74
BE - Belgio 65
CA - Canada 46
BD - Bangladesh 45
TR - Turchia 35
AR - Argentina 30
NL - Olanda 30
IQ - Iraq 29
MX - Messico 26
AT - Austria 25
IR - Iran 25
RO - Romania 24
ES - Italia 16
CZ - Repubblica Ceca 14
TN - Tunisia 13
UZ - Uzbekistan 12
ZA - Sudafrica 12
EC - Ecuador 11
MY - Malesia 11
PK - Pakistan 10
SA - Arabia Saudita 9
VE - Venezuela 9
CH - Svizzera 8
ID - Indonesia 8
CI - Costa d'Avorio 7
LB - Libano 7
NP - Nepal 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CO - Colombia 6
CR - Costa Rica 6
GR - Grecia 6
LT - Lituania 6
MA - Marocco 6
AZ - Azerbaigian 5
JM - Giamaica 5
KE - Kenya 5
PH - Filippine 5
UY - Uruguay 5
BG - Bulgaria 4
DZ - Algeria 4
HU - Ungheria 4
KZ - Kazakistan 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
AM - Armenia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BZ - Belize 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
Totale 13.902
Città #
Ashburn 851
Fairfield 667
Singapore 646
Woodbridge 399
Chandler 392
Ann Arbor 353
Houston 334
Wilmington 314
Seattle 287
Hong Kong 275
San Jose 270
Cambridge 231
Palermo 193
Moscow 170
Dublin 124
New York 124
Jacksonville 123
The Dalles 120
Zgierz 117
Los Angeles 108
Tokyo 107
Beijing 106
Nanjing 98
Medford 94
Ho Chi Minh City 91
Santa Clara 90
Dallas 89
Council Bluffs 87
Frankfurt am Main 83
Des Moines 66
Brussels 65
Hefei 63
Princeton 62
Lauterbourg 61
Helsinki 53
Altamura 51
Boardman 51
San Diego 49
Hanoi 48
Dearborn 42
Lawrence 42
Tulsa 41
Ludwigshafen am Rhein 39
São Paulo 39
Buffalo 35
Jinan 33
Shenyang 33
Chicago 30
Seoul 30
Kitzingen 29
London 27
Nanchang 27
Tianjin 27
Warsaw 27
Milan 25
Munich 25
Orem 25
Seongnam 24
Changsha 23
Phoenix 23
Venice 23
Jiaxing 21
Falls Church 20
Chennai 19
Kumar 18
Montreal 18
Rome 18
Bremen 17
Brooklyn 17
Atlanta 16
Ningbo 16
Stockholm 16
Tehran 16
Columbus 15
Guangzhou 15
Amsterdam 14
Nuremberg 14
Redwood City 14
Baghdad 13
Denver 13
Haiphong 13
Poplar 13
Saint Petersburg 13
Hebei 12
Lancaster 12
San Mateo 11
Auburn Hills 10
City of London 10
Hangzhou 10
Hillsboro 10
Shanghai 10
Boston 9
Brno 9
Dhaka 9
Izmir 9
Lanzhou 9
Norwalk 9
Rio de Janeiro 9
Tashkent 9
Verona 9
Totale 8.696
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 407
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 350
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 333
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 316
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 314
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 310
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 301
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 299
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 299
Founder mutations in BRCA1 and BRCA2 genes 295
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 281
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 279
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 276
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 271
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 266
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 266
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 263
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 262
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 253
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 253
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 252
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 250
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 248
Liquid Biopsy in Breast Cancer 248
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 247
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 239
VUS variants in BRCA genes of hereditary breast/ovarian cancer 239
A missense mutation associated to early onset breast cancer in a sicilian woman. 238
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 237
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 231
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 229
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 228
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 228
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 228
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 228
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 224
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 213
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 211
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 210
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 203
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 201
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 197
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 194
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) 191
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors 190
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) 176
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 173
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 172
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 170
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 167
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 165
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 160
RUOLO DI P53 E DEI GENI K-RAS ED H-RAS NELLA TUMORIGENESI DEI CARCINOMI DELLE GHIANDOLE SALIVARI 159
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 153
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 153
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 151
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 134
RUOLO DI P53 E DEI GENI K-RAS EDH-RAS NELLA TUMORIGENESI DELLE GHIANDOLE SALIVARI 134
TP53 mutations are not prognostic indipendent indicators in bladder cancer 122
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 121
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 99
null 25
Totale 14.212
Categoria #
all - tutte 41.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 0 0 95
2021/2022867 60 182 25 39 43 37 66 41 87 101 57 129
2022/20231.123 117 202 20 148 138 161 54 85 132 9 42 15
2023/2024567 36 69 36 46 29 132 58 60 1 10 4 86
2024/20251.454 21 78 66 128 72 63 120 135 88 211 181 291
2025/20264.861 439 185 297 373 453 756 634 484 355 732 153 0
Totale 14.212